News Archives - Page 156 of 1149 - BioHealth Innovation

News

VIRTUAL SBIR and OTHER NON-DILUTIVE FUNDING SOURCES WORKSHOP with 1:1 PARTNERING – March 17-18, 2021

Don’t miss a unique opportunity to discuss your biohealth technology innovation directly with Program Officers from NSF, various institutes at…

Super UserFebruary 22, 2021

News

VIRTUAL SBIR and OTHER NON-DILUTIVE FUNDING SOURCES WORKSHOP with 1:1 PARTNERING – March 17-19, 2021 (2)

Don’t miss a unique opportunity to discuss your biohealth technology innovation directly with Program Officers from NSF, various institutes at…

Super UserFebruary 22, 2021

News

2/28 Deadline to Apply for $ (oncology innovation)…

for The Rockville-based National Foundation for Cancer Research is accepting applications through Sunday evening, February 28, from academic laboratory and…

Super UserFebruary 22, 2021

News

Salisbury Award for Entrepreneurial Translational Research – NFCR

The National Foundation for Cancer Research is proud to present the Salisbury Award in honor of the Salisbury family’s vision…

Super UserFebruary 22, 2021

News

Cartesian Therapeutics Initiates Phase 2 Clinical Trial of First RNA-Engineered Cell Therapy for Frontline Cancer – Cartesian

Gaithersburg, MD, Feb. 22, 2021 – Cartesian Therapeutics, a fully integrated, clinical-stage biopharmaceutical company pioneering mRNA-engineered cell therapy in and beyond…

Super UserFebruary 22, 2021

News

Novavax Completes Enrollment of PREVENT-19, COVID-19 Vaccine Pivotal Phase 3 Trial in the United States and Mexico | Novavax Inc. – IR Site

GAITHERSBURG, Md., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious…

Super UserFebruary 22, 2021

News

Eyedea Medical Joins Baltimore’s LaunchPort™ Medtech Venture Center

The LaunchPort™ announced today that Eyedea Medical (https://www.eyedeamedical.com/) joined the Venture Center and will make the Port Covington, Baltimore location…

Super UserFebruary 22, 2021

News

John Mumm, CEO of Deka BioSciences, joins Rich Bendis on BioTalk

Deka BioSciences CEO, John Mumm, CEO of Deka BioSciences, virtually guests on BioTalk to discuss his history in the BioHealth…

Super UserFebruary 22, 2021

News

Maryland Today | Pandemic Fighter’s Priorities

One of the nation’s leading scientists in the desperate campaign to develop coronavirus vaccines—and in the Hollywood-esque triumph of succeeding…

Super UserFebruary 22, 2021

News

5 Questions with Paul Nolde, Fund Manager/Managing Director, Riverflow Growth Fund · BioBuzz

“5 Questions With…” is a weekly BioBuzz series where we reach out to interesting people in the BioHealth Capital Region…

Super UserFebruary 22, 2021

News

VIRTUAL SBIR and OTHER NON-DILUTIVE FUNDING SOURCES WORKSHOP with 1:1 PARTNERING – March 17-18, 2021

VIRTUAL SBIR and OTHER NON-DILUTIVE FUNDING SOURCES WORKSHOP with 1:1 PARTNERING – March 17-19, 2021 (2)

2/28 Deadline to Apply for $ (oncology innovation)…

Salisbury Award for Entrepreneurial Translational Research – NFCR

Cartesian Therapeutics Initiates Phase 2 Clinical Trial of First RNA-Engineered Cell Therapy for Frontline Cancer – Cartesian

Novavax Completes Enrollment of PREVENT-19, COVID-19 Vaccine Pivotal Phase 3 Trial in the United States and Mexico | Novavax Inc. – IR Site

Eyedea Medical Joins Baltimore’s LaunchPort™ Medtech Venture Center

John Mumm, CEO of Deka BioSciences, joins Rich Bendis on BioTalk

Maryland Today | Pandemic Fighter’s Priorities

5 Questions with Paul Nolde, Fund Manager/Managing Director, Riverflow Growth Fund · BioBuzz

About BioHealth Innovation

Contact

Connect

News

About BioHealth Innovation

Contact

Connect

Search